Published in Front Pharmacol on July 16, 2014
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Drug Des Devel Ther (2015) 0.91
Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis (2015) 0.86
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1. J Ovarian Res (2015) 0.84
Comparative transcriptome analysis of lufenuron-resistant and susceptible strains of Spodoptera frugiperda (Lepidoptera: Noctuidae). BMC Genomics (2015) 0.82
A tyrosine-reactive irreversible inhibitor for glutathione S-transferase Pi (GSTP1). Mol Biosyst (2016) 0.80
The Association between Gene-Environment Interactions and Diseases Involving the Human GST Superfamily with SNP Variants. Int J Environ Res Public Health (2016) 0.80
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS One (2015) 0.79
Editorial: the changing faces of glutathione, a cellular protagonist. Front Pharmacol (2015) 0.77
Differences in Redox Regulatory Systems in Human Lung and Liver Tumors Suggest Different Avenues for Therapy. Cancers (Basel) (2015) 0.76
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications. Dis Markers (2016) 0.75
Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A. Chem Res Toxicol (2015) 0.75
Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer. Genes (Basel) (2015) 0.75
Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sin B (2016) 0.75
Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncol Lett (2017) 0.75
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet (2003) 25.57
Epigenetics in cancer. N Engl J Med (2008) 17.36
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
DNA methylation: roles in mammalian development. Nat Rev Genet (2013) 6.65
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res (1999) 3.15
Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem (2001) 2.14
Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J Biol Chem (2002) 1.72
Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ (2010) 1.67
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res (2001) 1.63
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev (1998) 1.59
Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther (2001) 1.56
MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol (2011) 1.42
Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene (2006) 1.40
An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol (1990) 1.35
Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol (2010) 1.33
Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Cancer Res (2003) 1.24
Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet (2011) 1.23
Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer (2010) 1.22
Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen (2008) 1.18
A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5'-end of the GSTP1 CpG island. J Biol Chem (2000) 1.14
Structure of the human genomic glutathione S-transferase-pi gene. Gene (1989) 1.13
Cancer chemoprevention by targeting the epigenome. Curr Drug Targets (2011) 1.13
Epigenomics of leukemia: from mechanisms to therapeutic applications. Epigenomics (2011) 1.11
Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis (2008) 1.09
GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci (2012) 1.09
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS One (2012) 1.06
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica (2004) 1.04
Pi-class glutathione S-transferase: regulation and function. Chem Biol Interact (1998) 1.04
Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med (2010) 1.03
A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol (2002) 1.02
Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol (2004) 1.01
I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2002) 1.00
DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer. Urology (2007) 1.00
Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res (1998) 0.98
Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung. J Thorac Cardiovasc Surg (2005) 0.97
Epigenetics Offer New Horizons for Colorectal Cancer Prevention. Curr Colorectal Cancer Rep (2012) 0.97
Glutathione transferases as targets for cancer therapy. Anticancer Agents Med Chem (2009) 0.96
Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo (2010) 0.96
miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1. Lung Cancer (2012) 0.95
Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat Res (2011) 0.95
Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog (2007) 0.94
Epigenetic memory in mammals. Front Genet (2011) 0.93
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma. J Mol Diagn (2005) 0.92
GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med (2012) 0.92
Sp1-mediated transcriptional activation of the human Pi class glutathione S-transferase promoter. J Biol Chem (1996) 0.91
Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene (1998) 0.91
Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. Biochem J (2007) 0.89
Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med (2002) 0.88
Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules. Mol Pharmacol (2012) 0.88
DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol (2012) 0.88
Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog (2012) 0.87
Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Ann Hematol (2007) 0.86
Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnol Adv (2014) 0.86
Chromatin-modifying agents in anti-cancer therapy. Biochimie (2012) 0.86
Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol (2003) 0.85
Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay. J Urol (2011) 0.85
MicroRNAs in cancer management and their modulation by dietary agents. Biochem Pharmacol (2012) 0.84
Long and short non-coding RNAs as regulators of hematopoietic differentiation. Int J Mol Sci (2013) 0.83
Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells. Biochem Pharmacol (2004) 0.83
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex. Mol Endocrinol (2011) 0.83
Borderline and malignant phyllodes tumors display similar promoter methylation profiles. Virchows Arch (2009) 0.82
Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cells. Biochem Pharmacol (2001) 0.81
Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines. Biochem Pharmacol (2011) 0.80
Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem Pharmacol (2004) 0.80
Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas. Mod Pathol (2008) 0.79
Expression of glutathione S-transferase P1-1 in leukemic cells is regulated by inducible AP-1 binding. Cancer Lett (2004) 0.78
Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. Biochem Biophys Res Commun (2011) 0.78
Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells. Biochem Pharmacol (2004) 0.78
Expression of glutathione S-transferase P1-1 in differentiating K562: role of GATA-1. Biochem Biophys Res Commun (2003) 0.77
Phorbol ester responsiveness of the glutathione S-transferase P1 gene promoter involves an inducible c-jun binding in human K562 leukemia cells. Leuk Res (2001) 0.77
Clinical applications of molecular biomarkers in prostate cancer detection. Rev Med Chir Soc Med Nat Iasi (2010) 0.76
Advances in biomarkers for the early diagnosis of prostate cancer. Chin J Cancer (2010) 0.76
Transcriptional regulation of glutathione S-transferase P1-1 in human leukemia. Biofactors (2003) 0.76